gemfibrozil has been researched along with cyclic gmp in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (50.00) | 29.6817 |
2010's | 1 (50.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Beuve, A; Fakira, KA; Murphy, BA; Routh, VH; Song, Z | 1 |
Benke, K; Hartyánszky, I; Horváth, EM; Kökény, G; Mátyás, C; Merkely, B; Németh, BT; Oláh, A; Radovits, T; Ruppert, M; Sayour, AA; Szabó, G; Szabolcs, Z | 1 |
2 other study(ies) available for gemfibrozil and cyclic gmp
Article | Year |
---|---|
AMP-activated protein kinase and nitric oxide regulate the glucose sensitivity of ventromedial hypothalamic glucose-inhibited neurons.
Topics: Aminoimidazole Carboxamide; AMP-Activated Protein Kinases; Animals; Chlorides; Cyclic GMP; Cystic Fibrosis Transmembrane Conductance Regulator; Gemfibrozil; Glucose; Guanylate Cyclase; Male; Mice; Mice, Inbred C57BL; Neurons; Nitric Oxide; Nitric Oxide Synthase Type I; Rats; Rats, Sprague-Dawley; Receptors, Cytoplasmic and Nuclear; Ribonucleotides; Signal Transduction; Soluble Guanylyl Cyclase; Ventromedial Hypothalamic Nucleus | 2009 |
Pharmacological preconditioning with gemfibrozil preserves cardiac function after heart transplantation.
Topics: Animals; Coronary Vessels; Cyclic GMP; Gemfibrozil; Gene Expression Regulation; Heart; Heart Transplantation; Hemodynamics; Ischemic Preconditioning, Myocardial; Leukocytes; Male; Myocardium; Nitric Oxide Synthase Type III; Platelet Activation; Rats; RNA, Messenger | 2017 |